Skip to content

Regenxbio RGNX Increase Decrease In Operating Lease Right Of Use Assets

Increase Decrease In Operating Lease Right Of Use Assets at other companies

Aspen Aerogels logo
Aspen AerogelsASPN
-$1.07M-64.7%
SkyWest logo
SkyWestSKYW
-$1.45M-676%
GHM
Graham CorporationGHM
-$424K-28.9%
Radiant Logistics logo
Radiant LogisticsRLGT
-$3.26M-15.3%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$615K+8.6%
Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
$0-100%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept rgnx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's increase decrease in operating lease right of use assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's increase decrease in operating lease right of use assets?
Regenxbio (RGNX) reported increase decrease in operating lease right of use assets of -$1.71M in Q1 2026.
How has Regenxbio's increase decrease in operating lease right of use assets changed year-over-year?
Regenxbio's increase decrease in operating lease right of use assets decreased by 4.1% year-over-year, from -$1.64M to -$1.71M.
What is the long-term trend for Regenxbio's increase decrease in operating lease right of use assets?
Over 4 years (2021 to 2025), Regenxbio's increase decrease in operating lease right of use assets has grown at a 8.1% compound annual growth rate (CAGR), from -$4.87M to -$6.65M.
What does increase decrease in operating lease right of use assets mean?
This represents the non-cash change in the value of right-of-use assets recognized under lease accounting standards. It reflects the amortization of the asset over the lease term and adjustments for lease modifications or impairments. Tracking this helps investors understand the impact of long-term lease commitments on the company's balance sheet and cash flow reconciliation.